01-09-2023 | Hydroxychloroquine | Case report
Anifrolumab/anti-inflammatories/hydroxychloroquine
Prolonged QTc interval, ineffectiveness and off label use: case report
Published in: Reactions Weekly | Issue 1/2023
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event